Private equity investors GHO Capital Partners and Ampersand Capital Partners have announced a merger agreement for the ...

Abbisko’s small molecule drug pimicotinib has smashed the primary goal of a phase 3 trial for the treatment of tenosynovial ...

Rogers, chief scientific officer at Coronado Research, she shares insights on the evolving landscape of pharmaceutical ...

Gifthealth Partners with United Digestive to boost patient access and procedure prep. Gifthealth has announced a strategic ...

The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

Innovative radiotherapy offers a precision treatment alternative.

Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.

Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...

A new case study released by AllazoHealth reveals that a leading rare disease pharmaceutical company achieved a 10.4% ...

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...